2000
DOI: 10.1159/000055076
|View full text |Cite
|
Sign up to set email alerts
|

Docetaxel in der First- und Second-line-Therapie des Magenkarzinoms

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2005
2005
2005
2005

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 6 publications
(7 reference statements)
0
1
0
Order By: Relevance
“…The underlying mechanism is not completely understood but it seems that the induced neutropenia 'per se' promotes bacterial invasion of the intestinal wall and a necrotizing enterocolitis [14]. Interestingly, the combination of docetaxel and cisplatin is considered as a promising combination in neoadjuvant treatment of patients with stage III non-small cell carcinoma of the lung [15] as well as for first-and second-line therapy of gastric carcinoma because of tolerable toxicity [16]. Even corticosteroids are responsible for impaired macrophage function, bacterial invasion of the intestinal wall, and malakoplakia [14].…”
Section: Discussionmentioning
confidence: 99%
“…The underlying mechanism is not completely understood but it seems that the induced neutropenia 'per se' promotes bacterial invasion of the intestinal wall and a necrotizing enterocolitis [14]. Interestingly, the combination of docetaxel and cisplatin is considered as a promising combination in neoadjuvant treatment of patients with stage III non-small cell carcinoma of the lung [15] as well as for first-and second-line therapy of gastric carcinoma because of tolerable toxicity [16]. Even corticosteroids are responsible for impaired macrophage function, bacterial invasion of the intestinal wall, and malakoplakia [14].…”
Section: Discussionmentioning
confidence: 99%